-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Rain Oncology Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2022.
- Rain Oncology Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$8.08M, a 56.1% increase year-over-year.
- Rain Oncology Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$76.6M, a 6.91% decline year-over-year.
- Rain Oncology Inc. annual Operating Income (Loss) for 2022 was -$77.1M, a 49.7% decline from 2021.
- Rain Oncology Inc. annual Operating Income (Loss) for 2021 was -$51.5M, a 172% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)